WATSON 3159 (Ursodiol 300 mg)
Pill imprint WATSON 3159 has been identified as Ursodiol 300 mg.
Ursodiol is used in the treatment of biliary cirrhosis; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 3159 (Ursodiol 300 mg)
- 300 mg
- 22.00 mm
- Prescription only
- Drug Class:
- Gallstone solubilizing agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
|NDC Code||Manufacturer / Repackager|
|68084-0213||Amerisource Health Services|
Note: Inactive ingredients may vary.